Trichinella spiralis heat shock protein 70 (Ts-Hsp70) is a protective antigen that induces partial protective immunity against T. spiralis infection in mice. To determine whether dendritic cells are involved in the mechanism responsible for the protection induced by Ts-Hsp70, mouse bone marrow-derived dendritic cells (DCs) were incubated with recombinant Ts-Hsp70 (rTs-Hsp70), and the DC-secreted cytokines and expressed surface markers were measured. The results demonstrated that rTs-Hsp70 activated DC maturation that was characterized by the secretion of IL-1␤, IL-12p70, TNF-␣, and IL-6 and the increased surface expression of CD11c, MHC II, CD40, CD80, and CD86. The rTs-Hsp70-activated DCs enabled the stimulation, proliferation and secretion of Th1/2 cytokines (i.e., INF-␥, IL-2, IL-4 and IL-6) in CD4 + T cells from T. spiralis-infected mice. The mice that received rTs-Hsp70-activated DCs exhibited a 38.4% reduction in muscle larvae upon larval challenge with T. spiralis compared to the group that received PBS-incubated DCs. This partial protection was correlated with Th1 and Th2 mixed anti-Ts-Hsp70-specific immune responses that included high titers of total IgG, IgG1 and IgG2a and increased levels of Th1/2 cytokines (i.e., IFN-␥, IL-2, IL-4, IL-6). These results indicate that the rTs-Hsp70-induced protective immunity was mediated by the activation of the DCs and that rTs-Hsp70-loaded DCs could be an alternative vaccine approach against trichinellosis.
Introduction
Trichinellosis is a widespread and serious parasitic zoonosis. This disease is acquired by eating inadequately cooked or raw pork or other animal meat containing muscle larvae of the Trichinella parasite [1] . Human trichinellosis occur in more than 55 countries around the world, and trichinellosis is considered to be a reemerging disease in some parts of the world due to changes in diet and cooking practices and increasing meat consumption [1] [2] [3] . Trichinellosis is not only a public health hazard but also an economic problem in porcine animal production and food safety. This zoonosis is difficult to prevent and control due to the wide distribution of domestic and wild animal reservoirs and sources of human infection [4, 5] . Therefore, the development of a vaccine to prevent Trichinella infection in domestic animals and humans is a necessary approach for controlling this disease.
Heat shock proteins (Hsps) are a group of proteins that are induced upon exposure to a range of environmental stresses that include heat shock, oxygen deprivation, pH extremes, and nutrient deprivation [6] . This family of proteins is highly conserved among different species and highly immunogenic during infections [7] [8] [9] [10] . The heat shock proteins have recently been reported to play significant roles in antigen presentation, the activation of lymphocytes, and the maturation of dendritic cells [11] . Several researchers have also reported on the protective efficacies of Hsps against various infections by Plasmodium yoelii [7] , Brugia malayi [8] , Leishmania donovani [9] , and Hantaan virus [12] . Several heat-shock proteins, such as Hsp60, Hsp70 and Hsp80, have been reported and named according to their molecular weight. Of these proteins, Hsp70 is the most conserved among different organisms, and Hsp70 is an immunodominant antigen during infections caused by a number of pathogens [6, 13, 14] .
In our previous study, Hsp70 from Trichinella spiralis (Ts-Hsp) was cloned via the immunoscreening of a T. spiralis cDNA library with immune serum, and the recombinant Ts-Hsp70 protein (rTsHsp70) was expressed in an Escherichia coli expression system [15] . The rTs-Hsp70 protein was recognized not only by the sera from patients with trichinellosis but also in the sera from T. spiralisinfected rabbits, pigs, and mice. The native Ts-Hsp70 was found in the crude somatic extracts of T. spiralis muscle larvae and adult worms. Vaccination with rTs-Hsp70 induces a strong immune response and a 37% reduction in muscle larvae upon T. spiralis larval challenge compared to PBS control groups [15] . Further investigations in our lab demonstrated that the immunization of mice with rTs-Hsp70 elicited a systemic Th1/Th2 immune response (data not shown). However, as a possible vaccine candidate antigen, the mechanism of Ts-Hsp70-mediated protection requires further clarification.
One mechanisms by which an antigen is presented to the immune system is based on the antigen's ability to alter the maturation of dendritic cells (DCs). DCs are the typical antigen presenting cells (APCs) that induce primary immune responses through the activation and differentiation of helper T cells [16, 17] and play a crucial role in helminth infections [18, 19] . Currently, it remains unclear whether the protective immune response against T. spiralis infection induced by rTs-Hsp70 is related to DC activation. In this study, the interaction between rTs-Hsp70 and DCs derived from mouse bone marrow was investigated. The phenotypes, cytokine production and functions of the DCs were observed upon their interaction with rTs-Hsp70 in vitro, and whether adoptive transfer of rTs-Hsp70-pulsed DCs induced protective immunity against T. spiralis infection was investigated in mice.
Materials and methods

Parasites
The ISS 533 strain of T. spiralis was originally isolated from a swine source in the Hei Longjiang Province of China and was maintained by serial passage in ICR mice in our laboratory [20] .
Adult worms were collected from the intestines of infected mice, and muscle larvae (ML) were recovered from the muscles of infected mice via a previously described modified pepsin-hydrochloric acid digestion method [20] .
Animals
Female BALB/c mice aged 6-8 weeks that were free of specific pathogens were obtained from the Laboratory Animal Services Center of the Capital Medical University (Beijing, China). The mice were maintained under specific pathogen-free conditions with suitable humidities and temperatures.
All experimental procedures were approved by the Capital Medical University Animal Care and Use Committee and complied with the NIH Guidelines for the Care and Use of Laboratory Animals.
Recombinant protein preparation
The cDNA encoding full-length Ts-Hsp70 was subcloned in-frame into the pET-28a (+) vector (Novagen, USA). LPS contamination was less than 3 pg/g protein as determined by Limulus amebocyte lysate assay (BioWhittaker, USA). The recombinant protein of the N-terminal fragment (1-966 bp) of T. spiralis paramyosin (rTs-PmyN), another protective antigen that was identified in our lab [21] , was used as an irrelevant protein control.
Generation of bone marrow-derived DCs
DCs were produced from mouse bone marrow cells according to the procedure described in previous reports [22, 23] with some modifications. Briefly, mouse bone marrow cells were harvested from the femurs and tibias of sacrificed BALB/c mice. After removal of the red blood cells, the cells were resuspended at 1 × 10 6 cells/ml in RPMI-1640 medium containing 10% (v/v) FBS (Life Technologies), 10 mM glutamine, and penicillin/streptomycin. After culture for 3 h at 37 • C, the non-adherent cells were removed by two gentle washings with pre-warmed RPMI-1640 medium. The remaining adherent cells, of which more than 84% were CD14 + monocytes as detected by fluorescence-activated cell sorting (FACS), were cultured in fresh RPMI 1640 medium containing 10 ng/ml recombinant GM-CSF and 2 ng/ml IL-4 (Prospec, Israel) for 7 days with replenishment of the cytokines on days 3 and 5. On day 7 of cultivation, the non-adherent and low-adherent cells were harvested as immature DCs for activation with rTs-Hsp70.
In vitro DC stimulation assay
In this experiment, the immature DCs were cultured in medium containing 10 g/ml rTs-Hsp70 for 48 h. The culture supernatants were collected for measurement of the cytokines IL-1␤, IL-6, IL12p70, and TNF-␣ that were secreted by the stimulated DCs with an enzyme-linked immunosorbent assay (ELISA) kit (R&D, USA), and the cells were harvested to examine their surface markers by FACS. Briefly, the DCs were washed twice with 0.01 M PBS, and treated with Fc-blocking reagent for 20 min on ice and then incubated with the following anti-mouse antibodies: phycoerythrin (PE)-conjugated mAbs to CD11c and MHC II, and FITC-conjugated mAbs to CD40, CD80, and CD86 (BD Biosciences, USA). CD11c is also known as integrin ␣X and interacts with its complement integrin b2 (also called CD18). CD11c is widely employed as a marker of murine DCs. Thirty minutes later, the DCs were gently washed with 0.01 M PBS, resuspended at 5 × 10 6 cells/ml in PBS and detected by flow cytometry. In the control groups, LPS was added into the culture at 2 g/ml as a positive control. rTs-PmyN was used as an irrelevant protein control, and PBS was added as a blank control. To exclude the effects of possible contamination of the recombinant proteins by LPS, the inhibitor polymyxin B was added at 30 g/ml as a control in all tested groups.
Co-incubation of CD4 + T cells with rTs-Hsp70-stimulated DCs
Mouse CD4 + T cells were isolated from the spleens of BALB/c mice infected with 500 T. spiralis ML for 45 days using anti-CD4 magnetic beads (Miltenyi Biotec, Germany) following the manufacturer's instructions. The isolated cells contained 94% CD4 + cells as determined by FACS analysis. The isolated CD4 + T cells were resuspended at 5 × 10 5 ml −1 and co-incubated with 1 × 10 5 ml −1 DCs stimulated with rTs-Hsp70 or other controls as mentioned above and pretreated with mitomycin C. The co-incubation was continued for 48 h at 37 • C, and the cells were then harvested, washed, resuspended in fresh medium and seeded into 96-well flat-bottom cell culture plates. Next, 25 l 5 mg/ml MTS was added to each well, and incubation was continued for 4 h. The proliferation was measured using the MTS kit (Promega, USA), and the stimulation index was calculated according to the manufacturer's protocol.
To measure the cytokines secreted by the CD4 + T cells that were co-incubated with the stimulated DCs, 2 × 10 5 CD4 + T cells were co-incubated with rTs-Hsp70-stimulated DCs at a ratio of 5:1 in 96-well ELISPOT plates for 48 h at 37 • C. ELISPOT assays for detecting the CD4 + T cell-expressed IFN-␥, IL-2, IL-4 and IL-6 were performed as previously described [24] .
Adoptive transfer of rTs-Hsp70-stimulated DCs into mice
After being incubated with 10 g/ml rTs-Hsp70 for 48 h, the mouse bone marrow-derived DCs were washed twice in RPMI 1640 to remove the excess FBS and stimulator and then resuspended in PBS. Each female naïve BALB/c mouse in a group of 30 mice was injected intraperitoneally with 5 × 10 5 rTs-Hsp70-stimulated DCs. The DCs treated with LPS, rTs-PmyN and PBS were used as controls. All mice were transferred two more times with the same number of treated DCs at an interval of 2 weeks.
Humoral and cellular immune responses of the mice upon adoptive transfer of the rTs-Hsp70-stimulated DCs
The sera were collected through tail bleeding of the mice one week after each DC transfer and then every two weeks after last DC transfer until the 11th week (i.e., 0, 1, 3, 5, 7, 9, and 11 weeks). Anti-rTs-Hsp70 total IgG, IgG1, and IgG2a in the collected sera were detected by an indirect ELISA as described previously [25] . To measure the cytokines secreted by the splenocytes of mice that had been transferred with rTs-Hsp70-stimulated DCs, the splenocytes were isolated from 10 mice of each group 7 days after the last transferal with stimulated DCs, and the cell-secreted cytokines IFN-␥, IL-2, IL-4 and IL-6 were detected by ELISPOT assays as described above.
Analysis of worm burden
Ten days after the last DC transfer, each group of 10 mice was challenged with 500 T. spiralis ML. All mice were sacrificed 45 days after larval challenge, and the muscle larvae were collected as described previously. The larval reduction in the group of mice that were transferred with rTs-Hsp70-stimulated DCs compared to that of the group that was transferred with PBS-incubated DCs was calculated.
Reductions in larval burden in immunized mice were calculated according to the following formula:
% larvae reduction = 1 − mean number of larvae per gram muscle in immunized mice mean number of larvae per gram muscle in control mice × 100%
Statistical analysis
The data are shown as the mean ± the standard error (S.E.). All experiments were performed in triplicate. Statistical analyses were performed using GraphPad Prism 6 (GraphPad InStatt Software, USA). p < 0.05 was considered as statistically significant.
Results
rTs-Hsp70-stimulated maturation of DCs
FACS analysis revealed that both rTs-Hsp70 and LPS upregulated the expressions of MHC II, CD40, CD80 and CD86 on the DCs, but there was no effect on the expression of CD11c (Fig. 1A) . Neither the His-tagged control protein rTs-PmyN nor PBS affected the expressions of these markers.
To further determine whether rTs-Hsp70 stimulated the maturation of the DCs, the typical cytokines produced by mature DCs were measured. DC-secreted IL-1␤, IL-6, IL-12p70, and TNF-␣ were significantly elevated upon rTs-Hsp70 stimulation compared to the levels secreted by the DCs that were incubated with PBS or the non-relevant recombinant protein control (rTs-Pmy-N) (Fig. 1B) . The addition of polymyxin B inhibited the stimulation by LPS but not that of rTs-Hsp70. This finding excludes the effect of possible endotoxin contamination in the recombinant Ts-Hsp70.
Effects of rTs-Hsp70-activated DC-stimulated CD4 + T cells
After incubation with 10 g/ml of rTs-Hsp70 for 48 h, the DCs were pretreated with mitomycin C and then co-cultivated for 48 h with CD4 + T cells that had been isolated from the spleens of T. spiralis-infected. The proliferation of the T cells that was induced by the activated DCs was investigated using MTS kits. The results revealed that the proliferation of the CD4 + T cells was significantly induced by the rTs-Hsp70-activated DCs compared to PBS-and the non-relevant protein-(rTs-Pmy) incubated DCs (Fig. 2A) .
The levels of IFN-␥, IL-2, IL-4, and IL-6 secreted by the CD4 + T cells were measured following co-incubated with the DCs (Fig. 2B) . The production of both Th1 (IFN-␥ and IL-2) and Th2 cytokines (IL-4 and IL-6) were highly elevated in the cells that were incubated with rTs-Hsp70-activated DCs compared to the levels from cells that were incubated with the PBS-and non-relevant protein (TsPmy-N)-incubated DCs. Both the proliferation and cytokine results indicated that the rTs-Hsp70-activated DCs stimulated the CD4 T + cells of the T. spiralis infected mice.
3.3. Adoptive transfer of rTs-Hsp70-activated DCs induced both Th1 and Th2 immune responses to Ts-Hsp70 in mice rTs-Hsp70-activated DCs were passively transferred into naive mice three times with intervals of 14 days. The levels of anti-TsHsp70-specific IgG in the sera of these mice were significantly elevated, and these elevations lasted more than 11 weeks without declining (Fig. 3A) . The levels of the IgG subtypes were measured, and the results revealed that both IgG1 and IgG2a were induced at similar levels, which indicates that the Ts-Hsp70-activated DCs induced a mixed Th1 and Th2 response in the mice (Fig. 3B) . No anti-Ts-Hsp70 IgG was detected in the mice that received the DCs that were incubated with PBS, the non-relevant protein (Ts-Pmy-N) or LPS.
The cytokines IFN-␥, IL-2, IL-4, and IL-6 that were secreted by the splenocytes that were collected from the mice that were passively transferred with rTs-Hsp70-activated DCs were also measured. The secretions of the Th1 (IFN-␥ and IL-2) and Th2 cytokines (IL-4 and IL-6) were significantly elevated in the mice that received the TsHsp70-activated DCs compared those of the groups that received PBS-or non-relevant protein (Ts-Pmy-N)-incubated DCs (Fig. 4) .
Protective immunity induced by Ts-Hsp70-activated DCs
To determine whether the Ts-Hsp70-activated DCs were able to induce protective immunity against T. spiralis infection, the mice that received the DCs were challenged with T. spiralis infective larvae, and the worm burdens were examined at the end of the experiment. The mice that received the rTs-Hsp70-activated DCs exhibited a statistically significant 38.4% reduction in muscle larvae burden compared to the mice that received the PBS-incubated DCs (Fig. 5) . The mice that received recombinant Ts-Pmy-N-incubated DCs did not exhibit a significant reduction in worm burden upon T. spiralis larval challenge.
Discussion
DCs are central players in the induction and maintenance of immune responses and play a prominent role in helminth infections. The infection itself stimulates DC activity, and the infection-induced DC responses are critical for controlling and eliminating the invading agent [26] . In recent years, considerable progress has been made in elucidating the mechanisms behind the interplay between DCs and helminthes [18, 19, 26] . After interacting with some parasitic helminth antigens, DCs become mature [22, 27, 28] . The research into the activation and maturation of DCs that are stimulated by helminth antigens has provided a novel approach for the development of vaccines that directly target the antigen-presenting cells [13] .
Our previous results indicated that Ts-Hsp70 is a potential vaccine candidate for T. spiralis infection. In the present study, we confirmed that Ts-Hsp70 was able to directly activate mouse bone marrow-derived DCs to mature as characterized by the expressions of typical mature DC cytokines (i.e., IL-1␤, IL-6, IL-12p70, and TNF-␣) and surface markers (i.e., MHC II, CD40, CD80, and CD86). These results are consistent with the previous observations that T. spiralis antigens significantly induce the activation of dendritic cells [22, 29] .
Co-incubation of the rTs-Hsp70-activated dendritic cells with splenic CD4 + T cells from T. spiralis-infected mice induced strong proliferation of lymphocytes that secreted Th1 (i.e., INF-␥ and IL-2) and Th2 (i.e., IL-4 and IL-6) cytokines; these findings indicate that rTs-Hsp70-activated DCs enable the presentation of the rTs-Hsp70 antigen to CD4 + T lymphocytes and activate T-cells. The stimulation and activation of CD4 + T lymphocytes by the rTs-Hsp70-activated DCs were much stronger in the splenocytes from T. spiralis-infected mice (shown in this study) than in those from naïve mice (data not shown), which suggests that the rTs-Hsp70-sensitized memory cells acquired from natural infection were present in the splenocytes and pulsed by the presentation of Ts-Hsp70 by the activated DCs.
Antigen-loaded DC vaccines are a promising approach for infectious diseases. It has been reported that antigen-loaded DCs induce protective immunity against infections by intracellular bacteria [30] and protozoans [31] . Schnitzer et al. demonstrated that the protective immunity induced by the administration of antigenloaded DCs requires antigen processing and presentation by the recipient DCs [32] . Because rTs-Hsp70 was shown to be a potential vaccine antigen in our previous study and was shown to induce the activation of DCs in vitro in the present study, rTsHsp70-loaded DCs might be useful as an alternative strategy for immunization against T. spiralis infection. To determine whether rTs-Hsp70-activated DCs were able to convey protective immunity T. spiralis larvae challenge in naïve mice, mice were passively transferred with rTs-Hsp70-activated DCs. These mice produced Th1 and Th2 mixed anti-Ts-Hsp70-specific immune responses with high titers of anti-Ts-Hsp70 total IgG, IgG1 and IgG2a and significant increases in both Th1 (i.e., IFN-␥ and IL-2) and Th2 (i.e., IL-4 and IL-6) cytokines.
After challenge with 500 T. spiralis infective muscle larvae, the mice that received rTs-Hsp70-activated DCs exhibited a 38.4% reduction in muscle larvae compared to the group that received PBS-incubated DCs; this reduction is similar to that induced by immunization with rTs-Hsp70 (37%) as reported in another study [15] . Protective immunity induced by rTs-Hsp70-loaded DCs could possibly maintain long effect because the high anti-Ts-Hsp70 antibody titer did not decline over 11 weeks.
The partial protective immunity against T. spiralis infection induced by the rTs-Hsp70-loaded DCs shown in this study indicates the importance of dendritic cells in the immune response to Ts-Hsp70. Further investigation into the processing of Ts-Hsp70 in DCs and the presentation of processed Ts-Hsp70 epitope(s) to responding T-cells will increase our understanding of the protective immunity elicited by Ts-Hsp70 and provide further insight into increasing the vaccine efficacy of rTs-Hsp70 associated with the activation of DCs. The results of the present study also indicate the potential of using antigen-loaded DCs as a vaccine against trichinellosis.
